French startup Callyope has raised $2.4 million to develop a remote patient monitoring platform for mental health conditions such as schizophrenia and bipolar disorders, using voice-based monitoring. The technology will assist overburdened psychiatrists, notifying them so timely checks and preventive measures can be implemented to avoid relapses. The platform employs speech recognition and monitors other soft biomarkers.






